FI
KALA icon

Fosun International’s KALA BIO KALA Stock Holding History

Fosun International’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-99
Closed -$1.45M – 264
2019
Q2 		$1.45M Hold
99
– – 0.1% 131
2019
Q1 		$1.9M Hold
99
– – 0.12% 107
2018
Q4 		$1.21M Buy
+99
New +$1.72M 0.07% 120

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fosun International's KALA Position: Q3 2019 in Review

Fosun International sold out of KALA BIO (KALA) in Q3 2019, closing a stake of 99 shares — an estimated $1.45M sold.

Fosun International first reported a position in KALA in Q4 2018 and held it in 3 quarters. The position peaked at $1.9M in Q1 2019. 64 funds tracked by Wall St. Rank hold KALA as of Q3 2019.

  • Fosun International reported no remaining KALA BIO position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 99 KALA BIO shares in Q3 2019, an estimated $1.45M.
  • Fosun International first reported a position in KALA BIO in Q4 2018 and held it in 3 quarters.
  • Fosun International's KALA BIO position peaked at $1.9M in Q1 2019.
  • 64 funds tracked by Wall St. Rank held KALA BIO as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.